Trial reportThe Journal of international medical research2026
Effects of resistant starch on blood pressure and autonomic function in women with the risk of metabolic syndrome: A randomized double-blind pilot study.
Trial report in The Journal of international medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ObjectiveResistant starch is associated with metabolic benefits, but whether autonomic regulation links resistant starch intake to cardiovascular outcomes remains unclear. This study examined the effects of resistant starch on heart rate variability and blood pressure in women with features of metabolic syndrome.MethodsIn this 8-week randomized, double-blind pilot trial, 30 women (aged ≥ 40 years) with ≥2 metabolic syndrome components were assigned to a high-resistant starch or low-resistant starch group. The primary outcome was the change in systolic blood pressure from baseline to week 8. Secondary outcomes included heart rate variability-related autonomic parameters, whereas other blood pressure and metabolic syndrome-related variables were evaluated as exploratory outcomes.ResultsSystolic blood pressure decreased significantly within the high-resistant starch group (p = 0.037), although the baseline-adjusted between-group difference was not statistically significant. This change occurred without corresponding improvements in body mass index or triglyceride levels. Group-level heart rate variability differences did not reach statistical significance; however, exploratory analyses suggested a favorable directional pattern in global heart rate variability composite scores among participants with lower baseline autonomic activity (p = 0.06).ConclusionsHigh-resistant starch intake demonstrated exploratory signals of reduced systolic blood pressure and heart rate variability-related autonomic adaptation, particularly among participants with lower baseline autonomic activity. These findings warrant confirmation in adequately powered randomized controlled trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.